Dr. David Denning is trained in infectious diseases and has expertise in fungal diseases. He serves as the chief executive of Global Action For Fungal Infections, which advocates for universal access to diagnostics and antifungal medicines. Denning managed the United Kingdom’s National Aspergillosis Centre, Manchester from 2009-2020.